Mini-Review| Volume 30, ISSUE 3, P341-348, June 2017

Download started.


A Review of Expedited Partner Therapy for the Management of Sexually Transmitted Infections in Adolescents

Published:February 03, 2017DOI:


      Adolescents are at high risk of acquiring and becoming reinfected with sexually transmitted infections. Partner notification and treatment are essential to preventing the spread of sexually transmitted infections. Expedited partner therapy (EPT) is a method of partner treatment used by medical providers to treat patients' sexual partners without direct medical evaluation or counseling. The objective of this article is to review the current literature regarding EPT effectiveness, patients' attitudes and acceptance of EPT, and providers’ views and practices surrounding the use of this method of partner treatment. In this article potential concerns associated with EPT use, current policy statements, and the legal status of EPT are discussed. EPT results in improved or equivalent rates of reinfection in adolescents and adults with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Overall, patients are accepting of this method of partner treatment, however, providers continue to have concerns that limit its routine use. Additional studies in adolescents will help providers better understand if EPT is a useful method to prevent reinfection in this population.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Forhan S.
        • Gottlieb S.
        • Sternberg M.R.
        • et al.
        Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States.
        Pediatrics. 2009; 124: 1505
        • Satterwhite C.
        • Torrone E.
        • Meites E.
        • et al.
        Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.
        Sex Transm Dis. 2013; 40: 187
        • Centers for Disease Control and Prevention
        Sexually Transmitted Disease Surveillance 2013.
        US Department of Health and Human Services, Atlanta, GA2014
        • Tilson E.
        • Sanchez V.
        • Ford C.
        • et al.
        Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions.
        BMC Public Health. 2004; 4: 21
        • Gaydos C.
        • Wright C.
        • Wood B.
        • et al.
        Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers.
        Sex Transm Dis. 2008; 35: 233
        • Whittington W.L.
        • Kent C.K.
        • Kissinger P.
        Determinants of persistent and recurrent chlamydia trachomatis infection in young women: results of a multicenter cohort study.
        Sex Transm Dis. 2001; 28: 117
        • Burstein G.R.
        • Snyder M.
        • Conley D.
        Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization.
        Sex Transm Dis. 2001; 28: 477
        • Orr D.P.
        • Langefeld C.
        • Katz B.
        Behavioral intervention to increase condom use among high-risk female adolescents.
        J Pediatr. 1996; 128: 288
        • Orr D.P.
        • Johnston K.
        • Brizendine E.
        • et al.
        Subsequent sexually transmitted infection in urban adolescents and young adults.
        Arch Pediatr Adolesc Med. 2001; 155: 947
        • World Health Organization and Joint United Nations Programme on HIV/AIDS
        Sexually Transmitted Diseases: Policies and Principles for Prevention and Care.
        UNAIDS Best Practice Collection, Geneva1999
        • Centers for Disease Control and Prevention
        Expedited Partner Therapy in the Management of Sexually Transmitted Diseases.
        US Department of Health and Human Services, Atlanta, GA2006
        • Schillinger J.A.
        • Kissinger P.
        • Calvet H.
        • et al.
        Patient-delivered partner treatment with azithromycin to prevent repeat Chlamydia trachomatis infection among women: a randomized, controlled trial.
        Sex Transm Dis. 2003; 30: 49
        • Golden M.R.
        • Whittington W.L.
        • Handsfield H.H.
        • et al.
        Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.
        N Engl J Med. 2005; 352: 676
        • Kissinger P.
        • Mohammed H.
        • Richardson-Alston G.
        • et al.
        Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.
        Clin Infect Dis. 2005; 41: 623
        • Cameron S.T.
        • Glasier A.
        • Scott G.
        • et al.
        Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.
        Hum Reprod. 2009; 24: 888
        • Kissinger P.
        • Schmidt N.
        • Mohammed H.
        • et al.
        Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial.
        Sex Transm Dis. 2006; 33: 445
        • Schwebke J.R.
        • Desmond R.A.
        A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.
        Sex Transm Dis. 2010; 37: 392
        • Golden M.R.
        • Kerani R.P.
        • Stenger M.R.
        • et al.
        Uptake and population-level impact of expedited partner therapy (EPT) on chlamydia trachomatis and Neisseria gonorrhoeae: the Washington state community level trial of EPT.
        PLoS Med. 2015; 12: e1001777
        • Trelle S.
        • Shang A.
        • Nartey L.
        • et al.
        Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review.
        BMJ. 2007; 334: 354
        • Ferreira A.
        • Young T.
        • Matthews C.
        • et al.
        Strategies for partner notification for sexually transmitted infections, including HIV.
        Cochrane Database Syst Rev. 2013; 10: CD002843
        • Hogben M.
        • Collins D.
        • Hoots B.
        • et al.
        Partner services in sexually transmitted disease prevention programs: a review.
        Sex Transm Dis. 2016; 43: S53
        • Teplow-Phipps R.
        • Stockwell M.
        • Soren K.
        Adolescent chlamydia infection: treatment, expedited partner therapy, and testing for reinfection.
        Clin Pediatr (Phila). 2015; 54: 1383
        • DiClemente R.
        • Davis T.L.
        • Swartzendruber A.
        • et al.
        Efficacy of an HIV/STI sexual risk-reduction intervention for African American girls in juvenile detention centers: a randomized controlled trial.
        Women Health. 2014; 54: 726
        • Taylor M.
        • Reilley B.
        • Yellowman M.
        • et al.
        Use of expedited partner therapy among chlamydia cases diagnosed at an urban Indian health centre, Arizona.
        Int J STD AIDS. 2013; 24: 371
        • Mickiewicz T.
        • Al-Tayvib A.
        • Thrun M.
        • et al.
        Implementation and effectiveness of an expedited partner therapy program in an urban clinic.
        Sex Transm Dis. 2012; 39: 923
        • Kerns J.L.
        • Jones H.E.
        • Pressman E.J.
        • et al.
        Implementation of expedited partner therapy among women with chlamydia infection at an urban family planning clinic.
        Sex Transm Dis. 2011; 38: 722
        • Yu Y.Y.
        • Frasure-Williams J.
        • Dunne E.F.
        • et al.
        Chlamydia partner services for females in California family planning clinics.
        Sex Transm Dis. 2011; 38: 913
        • Stephens S.C.
        • Bernstein K.T.
        • Katz M.H.
        • et al.
        The effectiveness of pateint-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco.
        Sex Transm Dis. 2010; 37: 525
        • Vaidya S.
        • Johnson K.
        • Rogers M.E.
        • et al.
        Predictors of index patient acceptance of expedited partner therapy for Chlamydia trachomatis infection and reasons for refusal, sexually transmitted disease clinics, New York City, 2011 to 2012.
        Sex Transm Dis. 2014; 41: 690
        • Cameron S.T.
        • Glasier A.
        • Muir A.
        • et al.
        Expedited partner therapy for chlamydia trachomatis at the community pharmacy.
        BJOG. 2010; 117: 1074
        • Goldsworthy R.C.
        • Fortenberry D.J.
        Patterns and determinants of patient-delivered therapy uptake among healthcare consumers.
        Sex Transm Dis. 2009; 36: 25
        • Holloway I.W.
        • Jones H.E.
        • Bell D.L.
        • et al.
        Men’s preferences for sexually transmitted infection care services in a low-income community clinic setting in New York City.
        Am J Mens Health. 2011; 5: 208
        • Stenger M.R.
        • Kerani R.P.
        • Bauer H.M.
        • et al.
        Patient-reported expedited partner therapy for gonorrhea in the United States: findings of the STD surveillance network 2010-2012.
        Sex Transm Dis. 2015; 42: 470
        • Gursahaney P.R.
        • Jeong K.
        • Dixon B.W.
        • et al.
        Partner notification of sexually transmitted diseases: practices and preferences.
        Sex Transm Dis. 2011; 38: 821
        • Temkin E.
        • Klassen A.C.
        • Mmari K.
        • et al.
        A qualitative study of patients’ use of expedited partner therapy.
        Sex Transm Dis. 2011; 38: 651
        • Nuwaha F.
        • Kambugu F.
        • Nsubuga P.
        • et al.
        Efficacy of patient-delivered partner medication in the treatment of sexual partners in Uganda.
        Sex Transm Dis. 2001; 28: 105
        • Mohammed H.
        • Leichliter J.S.
        • Schmidt N.
        • et al.
        Does patient-delivered partner treatment improve disclosure for treatable sexually transmitted diseases?.
        AIDS Patient Care STDs. 2010; 24: 183
        • Radovic A.
        • Burstein G.R.
        • Marshal M.P.
        • et al.
        Adolescents’ attitudes toward expedited partner therapy for sexually transmitted infections.
        Sex Transm Dis. 2013; 40: 894
        • Buchsbaum A.
        • Gallo M.F.
        • Whiteman M.K.
        • et al.
        Sexually transmitted disease partner notification among African-American, adolescent women.
        Infect Dis Obstet Gynecol. 2014; 2014: 619632
        • Morris J.
        • Lippman S.
        • Philip S.S.
        • et al.
        Sexually transmitted infection related stigma and shame among African American male youth: implications for testing practices, partner notification, and treatment.
        AIDS Patient Care STDs. 2014; 28: 499
        • Hogben M.
        • McCree D.H.
        • Golden M.R.
        Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians.
        Sex Transm Dis. 2005; 32: 101
        • Jotblad S.
        • Park I.U.
        • Bauer H.M.
        • et al.
        Patient-delivered partner therapy for chlamydial infections: practices, attitudes, and knowledge of California family planning providers.
        Sex Transm Dis. 2012; 39: 122
        • Packel L.J.
        • Guerry S.
        • Bauer H.M.
        • et al.
        Patient-delivered partner therapy for chlamydial infections: attitudes and practices of California physicians and nurse practitioners.
        Sex Transm Dis. 2006; 33: 458
        • Rosenfeld E.
        • Marx J.
        • Terry M.
        • et al.
        Healthcare providers’ perspectives on expedited partner therapy for chlamydia: a qualitative study.
        Sex Transm Dis. 2015; 91: 407
        • Palvin N.L.
        • Parker R.M.
        • Piggin A.K.
        • et al.
        Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: the views of Australian general practitioners.
        BMC Infect Dis. 2010; 10: 274
        • Lee S.
        • Dowshen N.
        • Matone M.
        • et al.
        Variation in practice of expedited partner therapy for adolescents by state policy environment.
        J Adolesc Health. 2015; 57: 348
        • Hsii A.
        • Hillard P.
        • Yen S.
        • et al.
        Pediatric residents’ knowledge, use and comfort with expedited partner therapy for STIs.
        Pediatrics. 2012; 130: 705
        • McNulty A.
        • Teh M.F.
        • Freedman E.
        Patient delivered partner therapy for chlamydial infection-what would be missed?.
        Sex Transm Dis. 2008; 35: 834
        • Stekler J.
        • Bachmann L.
        • Brotman R.M.
        • et al.
        Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy.
        Clin Infect Dis. 2005; 40: 787
        • Khan A.
        • Fortenberry D.
        • Juliar B.E.
        • et al.
        The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.
        Sex Transm Dis. 2005; 32: 260
        • Kerani R.P.
        • Fleming M.
        • DeYoung B.
        • et al.
        A randomized, controlled trial of inSPOT and patient-delivered partner therapy for gonorrhea and chlamydial infection among men who have sex with men.
        Sex Transm Dis. 2011; 38: 941
        • Kerani R.P.
        • Fleming M.
        • Golden M.R.
        Acceptability and intention to seek medical care after hypothetical receipt of patient-delivered partner therapy or electronic partner notification postcards among men who have sex with men: the partner’s perspective.
        Sex Transm Dis. 2013; 40: 179
        • Adimora A.
        Treatment of uncomplicated genital chlamydia trachomatis infections in adults.
        Clin Infect Dis. 2002; 35: S183
        • Rubinstein E.
        Comparative safety of the different macrolides.
        Int J Antimicrob Agents. 2001; 18: S71
        • American College of Obstetrians and Gynecologists
        Expedited partner therapy in the management of gonorrhea and chlamydial infection. Committee opinion no. 632.
        Obstet Gynecol. 2015; 125: 1526
        • American Academy of Pediatrics
        Statement of endorsement-expedited partner therapy for adolescents diagnosed with chlamydia or gonorrhea.
        Pediatrics. 2009; 124: 1264
        • Society for Adolescent Medicine
        Expedited partner therapy for adolescents diagnosed with chlamydia or gonorrhea: a position paper for the Society for Adolescent Medicine.
        J Adolesc Health. 2009; 45: 303
        • Workowski K.A.
        • Bolan G.
        Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2015.
        MMWR Recomm Rep. 2015; 64: 1
      1. Centers for Disease Control and Prevention: Legal status of expedited partner therapy (EPT). Available: Accessed July 2016.